Teva Pharmaceutical Industries Limited ( TEVA) - Stock Earnings
TEVA Upcoming earnings
Estimated EPS and revenue columns are available to paid members.
| Date | EPS (actual / est.) | Revenue low (est.) | Revenue (actual / est.) | Revenue high (est.) |
|---|---|---|---|---|
| Nov. 3, 2026, midnight | — / — | — | — / — | — |
TEVA Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q4 | 480.0 million USD | 4.7 billion USD |
| 2026Q1 | 369.0 million USD | 4.0 billion USD |
| 2026Q2 | -576.0 million USD | 4.1 billion USD |
| 2026Q4 Est. | — | — |
| 2027Q1 Est. | — | — |
| 2027Q2 Est. | — | — |
TEVA Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -559.0 million USD | 15.8 billion USD |
| 2024 | -1.6 billion USD | 16.5 billion USD |
| 2025 | 1.4 billion USD | 17.3 billion USD |
| 2026 Est. | — | — |
TEVA
Price: $41.10
Dividend Yield: 2.45%
Earnings Per Share: 0.60 USD
P/E Ratio: 57.43
Exchange: NYQ
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Country: Israel
Volume: 6.4 million
Ebitda: -12.5 billionMarket Capitalization: 46.0 billion